arrow
M

Marco Lanzillotta

IRCCS Ospedale San Raffaele
H指数:27
被引数:4,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort

利妥昔单抗可限制IgG4相关疾病中的糖皮质激素使用:来自大型欧洲队列的真实世界证据

2026-03-190
PRE
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicenter observational study

弥漫性泛血管炎患者声门下狭窄的临床结局:一项国际多中心观察性研究的结果

2026-02-240
PRE
Maintenance treatment for type 1 autoimmune pancreatitis: effectiveness and development of the PrescrAIP relapse prediction model

1型自身免疫性胰腺炎的维持治疗:疗效及PrescrAIP复发预测模型的发展

2025-09-130
PRE
Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients

利妥昔单抗在IgG4相关疾病四种表型中的有效性与安全性:一项欧洲多中心队列研究,涉及115例患者

2025-08-190
PRE
Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease

对欧洲胃肠病学联盟关于IgG4相关消化系统疾病诊断和治疗指南的遵循

2025-07-220
OAAI
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

欧洲的1型自身免疫性胰腺炎: 临床概况和对治疗的反应

2024-05-014
OAAI